Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Capsoni, Franco ^a   Ongari, Anna Maria ^a   Reali, Eva ^b   Catania, Anna ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN DERIVATIVE; CD11B ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 8; MELANOCORTIN; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; URATE; CYTOKINE; URIC ACID;

ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PHAGOCYTOSIS; PROTEIN FUNCTION; RESPIRATORY BURST; SUPERNATANT; BIOSYNTHESIS; CRYSTALLIZATION; GOUT; IMMUNOLOGY; METABOLISM; NEUTROPHIL;

CRYSTALLIZATION; CYTOKINES; GOUT; HUMANS; MELANOCORTINS; MONOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; URIC ACID;

EID: 75649148603     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2827     Document Type: Article

References (29)

1. Catania A. The melanocortin system in leukocyte biology. J Leukoc Biol 2007, 81:383-392. 10.1189/jlb.0706426, 17041004.
2. Getting SJ. Targeting melanocortin receptors as potential novel therapeutics. Pharmacol Ther 2006, 111:1-15. 10.1016/j.pharmthera.2005.06.022, 16488018.
3. Luger TA, Brzoska T. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis 2007, 66(Suppl 3):iii52-5. 10.1136/ard.2007.079780, 17934097.
4. Brzoska T, Luger TA, Maaser C, Abels C, Böhm M. Alpha-melanocyte stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008, 29:581-602. 10.1210/er.2007-0027, 18612139.
5. Sarkar A, Sreenivasan Y, Manna SK. Melanocyte-stimulating hormone inhibits lipopolysaccharide-induced biological responses by downregulating CD14 from macrophages. FEBS Lett 2003, 553:286-294. 10.1016/S0014-5793(03)01029-9, 14572638.
6. Oktar BK, Yuksel M, Alican I. The role of cyclooxygenase inhibition in the effect of α-melanocyte-stimulating hormone on reactive oxygen species production by rat peritoneal neutrophils. Prostaglandins Leukot Essent Fatty Acids 2004, 71:1-5. 10.1016/j.plefa.2003.11.009, 15172677.
7. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM. The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996, 17:675-679. 10.1016/0196-9781(96)00037-X, 8804079.
8. Manna SK, Sarkar A, Sreenivasan Y. α-Melanocyte-stimulating hormone down-regulates CXC receptors through activation of neutrophil elastase. Eur J Immunol 2006, 36:754-769. 10.1002/eji.200535209, 16479540.
9. Capsoni F, Ongari A, Colombo G, Turcatti F, Catania A. The synthetic melanocortin (CKPV)2 exerts broad anti-inflammatory effects in human neutrophils. Peptides 2007, 28:2016-2022. 10.1016/j.peptides.2007.08.001, 17850921.
10. Cooper A, Robinson SJ, Pickard C, Jackson CL, Friedmann PS, Healy E. α-Melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J Immunol 2005, 175:4806-4813.
11. Haskell-Luevano C, Sawyer TK, Hendrata S, North C, Panahinia L, Stum M, Staples DJ, Castrucci AM, Hadley MF, Hruby VJ. Truncation studies of α-melanotropin peptides identify tripeptide analogues exhibiting prolonged agonist bioactivity. Peptides 1996, 17:995-1002.
12. Gatti S, Carlin A, Sordi A, Leonardi P, Colombo G, Fassati LR, Lipton JM, Catania A. Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions. J Surg Res 2006, 131:209-214. 10.1016/j.jss.2005.08.009, 16413580.
13. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006, 440:237-241. 10.1038/nature04516, 16407889.
14. Chen CJ, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, Akira S, Rock KL. MyD88-dependent IL-1 receptor signaling is essential for gout inflammation stimulated by monosodium urate crystals. J Clin Invest 2006, 116:2262-2271. 10.1172/JCI28075, 1523415, 16886064.
15. Getting SJ, Christian HC, Flower RJ, Perretti M. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 2002, 46:2765-2775. 10.1002/art.10526, 12384937.
16. Getting SJ, Lam CW, Chen AS, Grieco P, Perretti M. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J 2006, 20:2234-2241. 10.1096/fj.06-6339com, 17077300.
17. Murakami Y, Akahoshi T, Hayashi I, Endo H, Kawai S, Inoue M, Kondo H, Kitasato H. Induction of triggering receptor expressed on myeloid cells in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. Arthritis Rheum 2006, 54:455-462. 10.1002/art.21633, 16447220.
18. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968, 97:77-89.
19. Boyum A. Isolation of human monocytes with Nycodenz a new non-ionic iodinated gradient medium. Scand J Immunol 1983, 17:429-436. 10.1111/j.1365-3083.1983.tb00809.x, 6407099.
20. Landis RC, Yagnik DR, Florey O, Philippidis P, Emons V, Mason JC, Haskard DO. Safe disposal of inflammatory monosodium urate monohydrate crystals by differentiated macrophages. Arthritis Rheum 2002, 46:3026-3033. 10.1002/art.10614, 12428246.
21. Scott P, Ma H, Viriyakosol S, Terkeltaub S, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol 2006, 177:6370-6378.
22. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 1962, 115:453-66. 10.1084/jem.115.3.453, 2137509, 13872176.
23. Desaulniers P, Marois S, Pare G, Popa-Nita O, Gilbert C, Naccache PH. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. J Rheumatol 2006, 33:928-938.
24. Matsukawa A, Yoshimura T, Maeda T, Takahashi T, Ohkawara S, Yoshinaga M. Analysis of the cytokine network among tumor necrosis factor α, interleukin-1β, interleukin-8, and interleukin-1 receptor antagonist in monosodium urate crystal-induced rabbit arthritis. Lab Invest 1998, 78:559-569.
25. Serhan CN, Lundberg U, Weissmann G, Samuelsson B. Formation of leukotrienes and hydroxy acids by human neutrophils and platelets exposed to monosodium urate. Prostaglandins 1984, 27:563-581. 10.1016/0090-6980(84)90092-3, 6328582.
26. Hachicha M, Naccache PH, McColl SR. Inflammatory microcrystals differentially regulate the secretion of macrophage inflammatory protein 1 and interleukin 8 by human neutrophils: a possible mechanism of neutrophil recruitment to sites of inflammation in synovitis. J Exp Med 1995, 182:2019-2025. 10.1084/jem.182.6.2019, 2192242, 7500047.
27. Spilberg I, Bhatt AK. Crystal-induced chemotactic factor. Methods Enzymol 1988, 162:193-197.
28. Mugridge KG, Perretti M, Ghiara P, Parente L. Alpha-melanocyte-stimulating hormone reduces interleukin-1 beta effects on rat stomach preparations possibly through interference with a type I receptor. Eur J Pharmacol 1991, 197:151-155. 10.1016/0014-2999(91)90514-Q, 1655471.
29. Poole S, Bristow AF, Lorenzetti BB, Das RE, Smith TW, Ferreira SH. Peripheral analgesic activities of peptides related to alpha-melanocyte stimulating hormone and interleukin-1 beta 193-195. Br J Pharmacol 1992, 106:489-492. 1907488, 1327383.